Oncogenic RET receptors display different autophosphorylation sites and substrate binding specificities.

The Journal of Biological Chemistry
X LiuJ E Dixon

Abstract

The c-ret proto-oncogene encodes a receptor tyrosine kinase which plays an important role in neural crest as well as kidney development. Genetic studies have demonstrated that germ line mutations in the ret oncogene are the direct cause of multiple endocrine neoplasia (MEN) 2A and 2B, familial medullary thyroid carcinoma (FMTC), and Hirschsprung's disease. However, despite the large body of genetic and biological evidence suggesting the importance of RET in development and neoplastic processes, the signal transduction mechanisms of RET remain unknown. To begin to understand the molecular mechanisms of the disease states caused by mutations in RET, the patterns of autophosphorylation of the wild-type RET and the MEN mutants were studied using site-directed mutagenesis and phosphopeptide mapping. Among the 6 autophosphorylation sites found in the wild-type RET receptor, the MEN2B mutant lacked phosphorylation at Tyr-1096, leading to decreased Grb2 binding, while simultaneously creating a new phosphorylation site. These changes in autophosphorylation suggest that the MEN2B mutation may result in the more aggressive MEN2B phenotype by altering the receptor's signaling capabilities.

References

Dec 1, 1977·Proceedings of the National Academy of Sciences of the United States of America·F SangerA R Coulson
Nov 1, 1989·The Japanese Journal of Surgery·R A Decker, S A Wells
Oct 20, 1995·The Journal of Biological Chemistry·K DurickS S Taylor
May 1, 1995·Nature Genetics·B PasiniR Bocciardi
Sep 15, 1995·The Journal of Biological Chemistry·A PandeyV M Dixit
Mar 12, 1993·Cell·Z SongyangR J Lechleider
Jan 1, 1994·Annual Review of Cell Biology·P van der GeerR A Lindberg
Jul 1, 1993·Human Molecular Genetics·H Donis-KellerS A Wells

❮ Previous
Next ❯

Citations

Oct 13, 2006·Pituitary·Yoshiki MurakumoMasahide Takahashi
Oct 6, 2007·Endocrine Pathology·Andrea Z LaiLois M Mulligan
Oct 5, 2001·Trends in Genetics : TIG·S ManiéM Billaud
Oct 1, 1996·Proceedings of the National Academy of Sciences of the United States of America·Q C VegaG R Dressler
Aug 24, 2002·Thyroid : Official Journal of the American Thyroid Association·Michael BrauckhoffHenning Dralle
Feb 3, 2006·Genes & Development·Sanjay JainJeffrey Milbrandt
Nov 10, 2000·Journal of Medical Genetics·J R Hansford, L M Mulligan
Jun 21, 2005·Genetics·Renee D ReadRoss L Cagan
Dec 30, 1999·Journal of Endocrinological Investigation·M SantoroA Fusco
Nov 25, 1998·Proceedings of the National Academy of Sciences of the United States of America·A BardelliP M Comoglio
Aug 1, 2007·Journal of Neurochemistry·Jason A GustinJeffrey Milbrandt
Jul 28, 2012·Human Mutation·Brandy D HyndmanLois M Mulligan
Jul 12, 2011·Biochemical Pharmacology·Valentina NicoliniCinzia Lanzi
Jun 29, 2005·Cytokine & Growth Factor Reviews·Elena ArighiHannu Sariola
Aug 15, 2002·Biochemical and Biophysical Research Communications·Maria Grazia BorrelloMarco A Pierotti
Mar 7, 2013·Expert Opinion on Therapeutic Targets·Maria Grazia BorrelloMarco A Pierotti
Jun 5, 1999·Molecular and Cellular Neurosciences·M S AiraksinenM Saarma
May 30, 2009·Experimental Hematology·Elena RazumovskayaLars Rönnstrand
Jan 9, 2004·The Journal of Biological Chemistry·Yoshiyuki KawamotoIzumi Nakashima
Feb 10, 2004·The Journal of Biological Chemistry·Mario EncinasEugene M Johnson
Feb 2, 2011·Laboratory Investigation; a Journal of Technical Methods and Pathology·Hoon RyuJunghee Lee
Aug 8, 2002·Oncogene·Davy Chun Wai LeeSiu Yuen Chan
Nov 19, 2005·Journal of Neuroscience Research·Rebecca Hui Kwan LeeSiu Yuen Chan
Jan 20, 2018·Endocrine-related Cancer·Sara RedaelliLuca Mologni
Nov 28, 2017·Endocrine-related Cancer·Iván Plaza-Menacho
Jan 16, 2003·Oncogene·Maria Domenica CastelloneMassimo Santoro
Oct 16, 2007·Annals of Medicine·Pia Runeberg-Roos, Mart Saarma
Dec 15, 2000·Oncogene·S M Jhiang
Feb 23, 2020·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Vivek SubbiahFunda Meric-Bernstam
Jan 24, 1997·The Journal of Biological Chemistry·S D PanditL J Pike
Mar 12, 2002·The Journal of Biological Chemistry·Toshifumi FukudaMasahide Takahashi

❮ Previous
Next ❯

Related Concepts

Related Feeds

ASBMB Publications

The American Society for Biochemistry and Molecular Biology (ASBMB) includes the Journal of Biological Chemistry, Molecular & Cellular Proteomics, and the Journal of Lipid Research. Discover the latest research from ASBMB here.

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Autoimmune Polyendocrine Syndromes

This feed focuses on a rare genetic condition called Autoimmune Polyendocrine Syndromes, which are characterized by autoantibodies against multiple endocrine organs. This can lead to Type I Diabetes.